Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis: The MusiQoL-MCAT.
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
Plasma exchange in severe attacks of neuromyelitis optica.
Multiple sclerosis causing a partial sixth nerve palsy.
Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease.
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
PLEGRIDY™ (peginterferon beta-1a) approved in the European Union for the treatment of multiple sclerosis
Alemtuzumab (Lemtrada) - NICE says yes in final draft guidance
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
Product Insert, Amiloride HCl Tablets
European medicines agency's committee for medicinal products for human use issues positive opinion on marketing authorisation application for Fampyra
Structure and Activity of the Acid Sensing Ion Channels.
Rectus abdominis muscle endometriotic mass in a woman affected by multiple sclerosis.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
[Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a german high-volume clinic].

Pages